bortezomib

It is used in the treatment of multiple myeloma and mantle cell lymphoma in patients over 18 years of age.

Form: powder for solution for injection

ATC: L01XG01

Manufacturer: ACCORD HEALTHCARE, S.L.U.

This medicine is used for the treatment of multiple myeloma (a type of bone marrow cancer) and mantle cell lymphoma (a type of cancer that affects the lymph nodes) in patients over 18 years of age.

Form: powder for solution for injection

ATC: L01XG01

Manufacturer: Eugia Pharma (Malta) Limited

It is used for the treatment of multiple myeloma (a type of bone marrow cancer) and mantle cell lymphoma (a type of cancer that affects the lymph nodes) in patients over 18 years of age.

Form: powder for solution for injection

ATC: L01XG01

Manufacturer: DR. REDDY'S S.R.L.

This medicine is used in the treatment of multiple myeloma (a cancer of the bone marrow) and mantle cell lymphoma (a cancer of the lymph nodes) in patients over 18 years of age.

Form: solution for injection

ATC: L01XG01

Manufacturer: EG S.P.A.

It is used for the treatment of multiple myeloma (a bone marrow cancer) and mantle cell lymphoma (a lymph node cancer) in patients over 18 years of age.

Form: solution for injection

ATC: L01XG01

Manufacturer: EVER VALINJECT GMBH

It is used in the treatment of multiple myeloma (a bone marrow cancer) in patients over 18 years of age and for the treatment of mantle cell lymphoma (a lymph node cancer) in patients 18 years of age or older.

Form: powder for solution for injection

ATC: L01XG01

Manufacturer: FRESENIUS KABI DEUTSCHLAND GMBH

It is used in the treatment of multiple myeloma (a bone marrow cancer) in adult patients, either in combination with other medicines or alone, depending on the clinical situation. It is also indicated for the treatment of mantle cell lymphoma (a lymph node cancer) in association with other medicines.

Form: solution for injection

ATC: L01XG01

Manufacturer: GLENMARK PHARMACEUTICALS S.R.O.

It is used for the treatment of multiple myeloma (a type of bone marrow cancer) in adult patients and mantle cell lymphoma (a type of cancer that affects the lymph nodes) in adult patients.

Form: powder for solution for injection

ATC: L01XG01

Manufacturer: HIKMA PHARMA GMBH

The drug must be used exclusively via intravenous or subcutaneous administration. It must not be administered through other routes.

Form: powder for solution for injection

ATC: L01XG01

Manufacturer: MEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE MBH

It is used for the treatment of multiple myeloma (a cancer of the bone marrow) and mantle cell lymphoma (a type of cancer that affects the lymph nodes) in patients over 18 years of age.

Form: powder for solution for injection

ATC: L01XG01

Manufacturer: MYLAN S.P.A.

It is used in the treatment of multiple myeloma (a bone marrow cancer) and mantle cell lymphoma (a lymph node cancer) in adult patients.

Form: powder for solution for injection

ATC: L01XG01

Manufacturer: SANDOZ BV

This medicine is used for the treatment of multiple myeloma (a bone marrow cancer) and mantle cell lymphoma (a lymph node cancer) in patients over 18 years of age.

Form: powder for solution for injection

ATC: L01XG01

Manufacturer: SUN PHARMACEUTICAL INDUSTRIES (EUROPE) B.V.

It is used in the treatment of multiple myeloma (a type of bone marrow cancer) and mantle cell lymphoma (a type of lymph node cancer) in patients over 18 years of age.

Form: solution for injection

ATC: L01XG01

Manufacturer: JANSSEN-CILAG INTERNATIONAL N.V.